Skip to main content
. 2020 Aug;8(16):1000. doi: 10.21037/atm-20-5298

Figure 3.

Figure 3

Representative images before and after apatinib treatment in case 2. In this 39-year-old man with primary hepatocellular carcinoma, baseline contrast-enhanced CT (A) demonstrates irregular nodular with portal vein tumor thrombus. After 8 weeks of therapy with apatinib, there is over 30% decrease in diameter of the sum of target lesions through arterial-enhancing CT and MRI.